“Great content showing evolving development trends. High-quality talks, good variety of topics, good opportunities for networking.”
—Director, Formulation and Basic Pharmaceutical Sciences, MERCK
“Fascinating and valuable insights.”
—Senior Vice President, Pharmaceutical Development, VIKING THERAPEUTICS
“Terrific relevant case studies about modeling and measuring.”
—Research Scientist, ELI LILLY
Most of the drugs and APIs currently on the market are poorly water-soluble and need to have their bioavailability improved through the development of enabled formulations and patient-centric delivery mechanisms. Despite the promises of many “next generation” techniques, the biopharma industry continues to rely on refinements to amorphous solid dispersions and hot melt extrusions. Formulation professionals will continue to face challenges in the solubility and characterization of these drug delivery methods for years to come.
Now in its fifth year, the Drug Formulation, Solubility and Bioavailability conference is geared toward improving drug performance and therapeutic impact through enabled formulations and more effective delivery methods.
By popular demand, this conference also features the 2016 Solubility Seminar, a full-day intensive devoted to the solubility challenges faced by formulation professionals at every stage of their careers, with a special emphasis on working with amorphous solids. These challenges never go away, so make sure your skills are always up to date!
Pharma, biotech and drug delivery scientific professionals responsible for:
This Event May Also Be of Interest to: